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Peptoids for Biomaterials Science 
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a
   
Poly(N-substituted glycine) ÒpeptoidsÓ have conventionally been exploited for drug 
discovery and therapeutics due to their structural similarity to peptides, protease resistance, 
and relative ease of synthesis. This mini-review highlights recent reports of peptoid self-
assembled nanostructures and macromolecular interfaces relevant to biomaterials science. 
The results illustrate how the versatility of peptoid design and synthesis could be exploited 
to generate multifunctional, modular and precisely tunable biointerfaces and biomaterials.  
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1. Introduction 
Materials that can be conveniently tuned to present the 
biochemical, morphological and mechanical features of native 
biological systems are of special interest to biomaterials 
science.
1,2,3
 The incorporation of targeting elements minimizes 
the potential of negative systemic effects, an important 
translational consideration.
1
 These ideas have inspired 
significant research in peptidic biomaterials
3,4
 as well as the 
chemical functionalization of naturally-derived and synthetic 
polymers.
2,5
 Poly(N-substituted glycine) ÒpeptoidsÓ (Figure 
1A), a class of highly customizable peptidomimetic 
macromolecules, could also potentially enable significant 
advances in biomaterials science. 
 Peptoids
 
 were developed in the late 1980s for 
combinatorial drug discovery as synthetically convenient, 
modular, peptidomimetic molecules.
6,7
 They are structural 
isomers of peptides with sidechains connected to the amide 
nitrogens instead of the α-carbons (Figure 1A). This structural 
change confers resistance to protease degradation.
7-9
 The 
sidechain shift results in tertiary amide linkages, leading to a 
backbone that is achiral and that has no H-bond donors. These 
properties confer substantial conformational flexibility in the 
main chain.
10-14
 Chirality and control over secondary and higher 
order structure formation can be reintroduced by sidechain 
chemistry and sequence designs.
10,12,13,15
 
 Synthetic convenience and modularity in generating 
sequences with monomer-level programmability over sidechain 
chemistry and chain length derive largely from the introduction 
of the submonomer solid phase synthesis by Zuckermann et al. 
(Figure 1B).
7,16
 No backbone protection is required and diverse 
primary amines, many of which are commercially available, 
can be incorporated as sidechains in an iterative protocol. Over 
250 different residues, including analogs or close mimics of all 
the canonical amino acids, have been demonstrated.
17,18
 
Peptoids of up to 100 residues in length have been 
demonstrated by coupling together two submonomer-
synthesized 50-mers.
19
 Alternatively peptoids can be 
synthesized with high degrees of polymerization > 100,
20
 but 
with limitations in sequence control, by the living 
polymerization of N-carboxy anhydride (NCA) monomers 
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(Figure 1C).
21-23
 The polymer of sarcosine, which is the analog 
of alanine and the simplest peptoid, was actually known from 
early investigations into living polymerization.
21
 The list of 
peptoid monomers available to NCA polymerization has been 
significantly expanded in recent years.
21,22
 
 The biorecognition abilities of peptoids have been 
demonstrated through two decades of peptoid therapeutics 
research, protein-binding sequence discovery, and secondary 
structure design, which have been recently reviewed 
elsewhere.
10,15,24-27
 As originally envisioned,
7
 many bioactive 
sequences have been discovered by screening peptoid 
libraries.
8,13
 These include antimicrobial peptoidsÑa significant 
area of peptoid research discussed in recent reviews.
10,25,27
 
Recent studies have also demonstrated peptoid sequences 
potentially useful in diagnosing or treating amyloid diseases.
28
  
 This mini-review highlights the recent developments in 
peptoids research which extend into the field of biomaterials 
science. A number of recent reviews have focused on how the 
synthetic accessibility and sequence programmability in 
chemistry and chain length of peptoids have generated broad 
potential in macromolecular and nanostructure 
engineering.
12,13,21,22
 This mini-review first discusses the 
biomaterial applications of these self-assembled structures. 
Attention is then turned to peptoid macromolecular interfaces 
and platforms that could offer unique possibilities. The aim is 
to illustrate how the versatility in peptoid design and synthesis 
can lead to macromolecular architectures with high potential in 
biomaterials science. 
        
   
Figure 1. Peptoid chemical structure and synthesis. A) A 
shift in the sidechain connection from the α-carbon to the amide 
nitrogen, accompanied by loss of main chain chirality and 
amide hydrogens, differentiates peptoids from peptides (L-
amino acid residue shown). B) Submonomer solid phase 
synthesis: residue coupling is split into elongating the chain via 
acylation with a haloacetic acid and sidechain introduction via 
displacement with a primary amine submonomer. DIC: N,N'-
Diisopropylcarbodiimide. C) NCA peptoid polymerization. 
2. Self‐Assembled Systems 
2.1 Molecular (Hydro)gelators 
 A pair of studies by Wu et al.
29
 and Mangunuru et al.
30
 
demonstrate that low molecular weight peptoid sequences could 
be utilized as gelators. Wu et al. picked a sequence of four 
peptoid analogs of phenylalanine (Phe) as the gelation motif 
(Figure 2; peptoid phenylalanine is shortened to NPhe below). 
The tetrapeptoid (NPhe)4 was linked via a glycine residue to 
tripeptides with demonstrated bioactivity (RGD, YSV and 
VPP), as well as a triglycine GGG control. Gels of all four 
sequences could be formed in phosphate buffered saline at a 
concentration of 10 mg/mL at pH 7.4. However the behavior of 
standalone (NPhe)4 and (NPhe)4G were not reported. The 
hydrogels were composed of either nanosheets or nanofibrils 
(Figure 2A-C), and the highest shear storage modulus was 
observed for (NPhe)4GGGG (750 Pa over 0.1-100 rad/s). The 
viabilities of several cell lines in solutions of the peptoids were 
not seriously affected (tested up to 200 µM). Fibroblasts also 
cultured well on the (NPhe)4GRGD and, especially, on the 
(NPhe)4GYSV gels. Finally, it was demonstrated that the 
(NPhe)4 sequence, but not (D-Phe)4 nor (L-Phe)4, was effective 
in protecting the pendant RGD sequences from degradation by 
proteinase K.  
 In a different approach, Mangunuru et al. scanned for 
gelators among a small library synthesized by Ugi one-pot four-
component reactions.
30
 Single peptoid residues functionalized 
at both the C and N ÒterminiÓ were generated. Many of the 
sidechain functional groups investigated have previously been 
demonstrated using the submonomer solid phase protocol.
17
 
Although Mangunuru et al. reported only gels formed in water 
mixed with ≥33% ethanol or dimethyl sulfoxide (DMSO), this 
work highlighted the chemical tunability possible with peptoids 
and the chemical groups that could promote peptoid gelation.  
 
    
Figure 2. Peptoid hydrogels. TEM images of hydrogels composed 
of A) (NPhe)4GGGG, B) (NPhe)4GRGD, C) (NPhe)4GYSV, and D) 
(NPhe)4GVPP. The first two hydrogels were composed of sheet-like 
microstructures while the latter two were formed from filamentous 
structures. Adapted from Ref. 29 with permission from The Royal 
Society of Chemistry.  
 The best gelators reported by Mangunuru et al. exhibited 
substituted aryl, cyclohexyl or protected glucosamine groups, 
while combinations with unsubstituted benzyl groups did not 
gel well. This is in apparent contrast to the gelation of the 
(NPhe)4 hybrids reported by Wu et al. However, the multiple 
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unsubstituted benzyls in the (NPhe)4 motif could induce a 
larger hydrophobic interaction between the peptoids. 
Juxtaposition of (NPhe)4 with the hydrophilic peptide 
sequences could also induce amphiphile self-assembly. In fact, 
the combination of hydrophobic and amphiphile interactions 
feature prominently in the self-assembly of many peptoid 
nanostructures, as described below. 
2.2 Nano and Micro Structures 
NANOSHEETS which are two molecular layers thick and water 
soluble have recently been applied as an antibody-mimetic 
platform by Zuckermann et al. (Figure 3).
31
 The researchers had 
earlier found that nanosheets can be assembled at the air-water 
interface from sequences that laterally align to form two 
opposing layers (Figure 3B).
32,33
 Assembly required the 
electrostatic interaction between oppositely charged peptoid 
residues, and the alternation of hydrophilic and hydrophobic 
residues such that a hydrophobic core can be formed between 
the opposing layers (Figure 3A-C). Overall sequence lengths of 
12 or more residues were required to build up a sufficiently 
attractive interaction. Zuckermann et al. then inserted 
oligopeptide segments with known recognition properties 
between peptoid sequences possessing the periodic self-
assembly motif (Figure 3D). These sequences also assembled 
into nanosheets, with the oligopeptides Òsqueezed outÓ as 
dangling loops. The nanosheets thus acted as a structural 
scaffold for the presentation of biorecognition loops and 
mimicked the conceptual structure of antibodies (Figure 3E).  
 Molecular recognition was demonstrated by three examples: 
i) the serine of a consensus peptide of casein kinase II presented 
on the nanosheets could be phosphorylated by the enzyme; ii) 
proteases were able to digest the presented peptides without 
disrupting the nanosheets; and iii) gold nanocrystals could be 
grown from E. coli gold-binding peptides presented on the 
nanosheets. The peptoid nanosheets do not aggregate in buffer, 
possibly due to the zwitterionic nature of the nanosheet surface 
(Figure 3B). There is no critical peptoid concentration once the 
nanosheets have been assembled but the sheets can be designed 
to re-dissolve at a certain pH by tuning the sequence 
arrangement.
33
 Being 2D objects, the nanosheets possess a high 
surface area to mass ratio, and could provide a high degree of 
cargo loading using either the hydrophobic core or a 
functionalized surface. Together with the commercial 
availability of the peptoid submonomer precursors used in the 
self-assembly motif and the modularity of the sequence design, 
the nanosheets hold significant promise for a range of delivery 
and sensing applications.  
NANO AND MICRO FIBRIL self-assembly have been 
demonstrated for peptoids synthesized by both the submonomer 
solid phase and NCA polymerization routes. The Zhang group 
investigated
34
 NCA diblock copolypeptoids composed of 
blocks with methylene (i.e. sarcosineÑhydrophilic
21,35
) and 
hydrophobic decyl sidechains. These block copolymers were 
found to self-assemble into spherical micelles that, over the 
course of several days, transitioned into cylindrical micelles 
with core diameters of 12 nm.
34
 Zuckermann et al. found solid 
phase synthesized amphiphilic diblock sequences that could 
self-assemble, first into nanosheets that then rolled (also over 
the course of several days), into microfibrillar helices.
36
 The 
ability to dial in specific block lengths and arrangements with 
the submonomer protocol was used to show that self-assembly 
required both hydrophobic and ionic interactions of amphiphilic 
sequences.  
 
Figure 3. Peptoid nanosheets. A) Chemical structure of a model 
sequence that can self-assemble into nanosheets, and B) partial view 
of the nanosheet molecular model showing the sequestration of 
hydrophobic phenyl-terminated sidechains and the outward 
presentation of the amine- and carboxylic acid-terminated sidechains 
(red: oxygen; blue: nitrogen; yellow: carbon). C) Free-floating sheets 
imaged by fluorescence optical microscopy, stained by Nile Red that 
had sequestered into the hydrophobic interior of the bilayers. D) 
Chemical structure of a sequence that formed antibody-mimetic 
nanosheets, as illustrated in (E). Reprinted with permission from 
Ref. 31 (Copyright 2013 American Chemical Society) and from Ref. 
33 (Copyright 2011 Wiley Periodicals). 
 
NANOPARTICLES have been associated with the earliest peptoid 
research. Sequences with repeating triplet cationic-
hydrophobic-hydrophobic motifs were found to form 
nanoparticulate DNA-peptoid complexes that were efficient 
gene transfection agents.
37
 Similar sequences, as well as 
polyamphoteric ones, have recently been shown to form 
microspheres.
38
 In a different line of research, hydrophilic 
polysarcosine synthesized by NCA polymerization have been 
exploited for controlling the water solubility of amphiphilic 
peptoid-peptide/polymer block copolymers that self-assemble 
into (nano)particles for controlled release and imaging 
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applications.
39
  
3. Macromolecular Interfaces and Platforms  
3.1 Antifouling Peptoids  
Peptoid chains grafted on solid surfaces as polymer brushes 
have been demonstrated to confer excellent resistances against 
protein adsorption and cell attachment.
35,40-43
 Several peptoid 
sidechains and chain lengths have been investigated. 
Intriguingly, polymer brushes composed of sarcosine, the 
peptoid with the simplest sidechain (a single methylene: Figure 
4), exhibited antifouling performance that is similarly excellent 
as peptoids with methoxyethyl sidechains that resemble the 
repeating unit of PEG.
35,40,42
 In both cases, protein adsorption 
could essentially be prevented at chain lengths of just 20 
repeating units, and long term fibroblast attachment could also 
be prevented (Figure 4).
35,40
 The resistance against bacteria 
attachment ranged from 75% to 99% (1 d), depending on the 
combination of the sidechain and the bacteria strain being 
tested.
35,41
  
 
 
Figure 4. Antifouling polysarcosine surface grafted peptoid 
brush. The left shows the schematic, chemical structure and 
molecular dynamics snapshot of the polysarcosine 20-mer used in 
antifouling experiments. The fluorescence micrographs on the right 
show that the number of 3T3 mouse fibroblasts attached on the 
polysarcosine-coated surface was very low through 7 wk, while a 
confluent layer was achieved on the uncoated TiO2 control surface 
during the same period (only 7 wk data shown). Fresh fibroblasts 
were reseeded on the samples twice a week. Although some cells 
were observed on the polysarcosine surface, their morphologies were 
rounded, exhibiting few filopodia, and were poorly attached. 
Reprinted with permission from Ref. 35. Copyright 2012 American 
Chemical Society. 
 According to molecular theory, the chain length and 
grafting density of a well-solubilized, flexible polymer brush 
dominate its antifouling performance.
42,44
 As such the short 
persistence length and inherent flexibility of the peptoid 
backbone,
11
 conferred by its achirality and the isomerization 
between trans and cis conformations,
14
 render hydrophilic 
peptoids an attractive antifouling platform. Consistent with this 
observation, excellent antifouling performance was also shown 
for β-peptoids with methyl and ethyl sidechains.
45
 Last but not 
least, the flexibility in peptoid synthesis enables convenient 
functionalization of antifouling peptoid biointerfaces, as 
demonstrated by peptoid brushes decorated with saccharides
46
 
and antimicrobial peptides.
41
 
3.2 Clickable Multivalent Scaffolds 
Using the submonomer protocol, Kirshenbaum et al. 
demonstrated that azide-alkyne cycloaddition on alkyne- or 
azide-terminated sidechains can be used to attach, in a 
sequence-specific manner, multiple and multifarious functional 
groups that are otherwise difficult to incorporate.
47
 These 
included estradiol, a hormone, and the electrochemically active 
ethynylferrocene. Polysaccharide mimics that can efficiently 
bind Concanavalin A have been demonstrated by clicking on 
mannose sidechains to a peptoid scaffold.
48
 The easy and 
precise chain length control by submonomer peptoid synthesis 
was exploited to determine that efficient binding to 
Concanavalin A required peptoid-mannose sequences of five or 
more residues. Similarly, control in the attachment positions of 
aminoglycoside sidechains clicked onto a peptoid backbone, 
separated by ÒspacerÓ residues with propyl sidechains, was 
used to tailor the specificity in the aminoglycoside targeting of 
RNAs that cause myotonic muscular dystrophy.
49
 Furthermore 
polyglycerated and polyglycosylated peptoids have been 
demonstrated by thiol-ene click addition to a NCA polymerized 
peptoid with allyl sidechains.
50
 Peptoid macrocycles with 
alkyne-terminated sidechains have also been synthesized by 
both the submonomer protocol
51
 and NCA polymerization.
52
 
Depending on the sequence, the macrocycles could crystallize 
and adopt two interconvertable conformations and reversibly 
sequester water.
51
  
3.3 Peptoid Libraries for Materials Discovery.  
Peptoid combinatorial libraries have been fruitfully used for 
therapeutics and protein-binding sequence discovery (see 
Introduction). Recent reports highlight the utility of the 
approach for materials applications. The concept has been 
applied to the discovery of small molecule gelators from a 
small library (see section 2.1). Kodadek et al. has developed
53
 a 
cell-based assay for screening vascular endothelial growth 
factor receptor 2 (VEGFR2)-binding peptoids that could 
potentially be adapted for biomaterials discovery. Cells 
expressing VEGFR2 were fluorescently labelled and exposed to 
PEG-co-PS solid phase synthesis resin beads (140-170 µm in 
diameter), each displaying one of over 250,000 possible peptoid 
9-mers generated by split-pool combinatorial synthesis from 8 
different peptoid residues in 8 reaction vessels. Beads on which 
VEGFR2-expressing cells attached were selected for automated 
Edman sequencing of the ÒhitÓ peptoids for further affinity 
refinement. In effect, each bead acted as a test well in a multi-
well plate cell attachment assay for parallel evaluation of cell 
behavior.  
 In the area of (bio)mineralization, library investigation of 
amphiphilic peptoids with specific sequences of hydrophobic 
and acidic sidechains discovered sequences that could 
accelerate calcite crystal growth by 23-fold at only 50 nM  
peptoid concentration (compared with enhancement factors of 
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1.64 or less by acidic peptides of similar molecular weights).
54
 
In a different study, trimers of a hydroxylated peptoid residue 
(analog of serine) were discovered to exhibit dual-action 
antifreeze effectsÑenhanced ice growth inhibition and melting 
temperature reduction.
55
 Both studies found that the sequence 
of peptoid additives could be used to control the crystal 
morphology, and that specific sequences likely altered the 
interactions of water molecules with the crystallizing surfaces. 
These reports also illustrate that libraries of sequence-specific 
peptoids enable the mechanistic investigation of how variations 
in chemical structure alter performance. 
4. Summary and Outlook  
The studies reviewed indicate the wide range of potential 
biomaterial and biointerfacial applications enabled by peptoids. 
Peptoid hydrogelators that are compatible with cell culture have 
been found. The modular design of self-assembled peptoid 
nanosheets with bioactive sequences has been demonstrated, 
opening up potential applications in drug delivery and 
biosensing. Peptoid nano and micro fibrils can also be self-
assembled, and peptoid nanoparticles have been explored for 
gene transfection and controlled release applications. 
Biointerfaces in the guise of antifouling peptoid polymer 
brushes that can be further functionalized with saccharides and 
antimicrobial peptides have been demonstrated. Clickable 
multivalent peptoid scaffolds lower the synthetic barrier to the 
introduction of complex sidechains and polysaccharide mimics.  
In addition, peptoid libraries hold significant promise for 
biomaterials discovery.  
  The knowledge gained from two decades of peptoid 
peptidomimetics research
10,13,24-26,56
 could potentially be 
quickly translated for biomaterials applications. Design rules 
for dialing in secondary structure and peptoid folding by 
sidechain design and sequence control have emerged.
10,13,15
 A 
catalogue of bioactive peptoids has been included in a recent 
review.
17
 Peptoids have also been shown to exhibit enhanced 
cell penetration compared to the corresponding peptide 
sequences,
57
 but they can also be tuned, as in the case of some 
antimicrobial peptoids, to target bacterial membranes.
58
 
Although the increased conformational flexibility of the peptoid 
backbone is expected to decrease binding affinity
24
 (e.g. 
integrin receptor binding by direct peptoid analogs of RGD was 
either not reported
59
 or not elicited
60
), certain peptoid sequences 
lacking secondary structure appear to possess activities superior 
to their structured counterparts.
10,58,61
 The resistance of peptoids 
against protease degradation
8,9,18,31,41
 is also potentially 
beneficial for protecting a pharmacological cargo,
37
 enhancing 
stability and bioavailability,
6,7,24
 and long-term biomedical 
applications, such as antifouling coatings.
40
  
 A continuing catalyst for peptoids research is the relative 
synthetic ease with which the sidechain chemistry and sequence 
can be precisely tuned to achieve the desired property. Stimuli-
responsiveness encoded by the sequence design would 
undoubtedly be advantageous, and pH,
33
 temperature
62
 and 
solvent condition
19
 effects have been reported. Peptoids could 
be used to mediate nanoparticle assembly
63
 and to enhance the 
stability of nanoparticles in difficult ionic conditions.
64
 
Biodegradability could potentially be reintroduced by inserting 
suitable peptide sequences. An interesting challenge remains in 
the routine synthesis of long, sequence-specific peptoids (e.g. > 
100 residues, as in many protein amino acid sequences). 
Ultimately, a bright future awaits the application of peptoids in 
biomaterials science as researchers further exploit the 
knowledge gained through peptoid therapeutics research and 
the highly accessible chemical versatility, self-assembly 
capabilities, and other intrinsic properties of peptoids.  
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